Skip to content

The Combination of PECS II Block and Parasternal Block for Radical Mastectomy

The Combination of PECS II Block and Parasternal Block Provide Useful Analgesia After Radical Mastectomy With Axillary Dissection and Implant Breast Reconstruction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03754816
Enrollment
65
Registered
2018-11-27
Start date
2018-12-01
Completion date
2019-04-12
Last updated
2019-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

PECS II block, parasternal block, analgesia

Brief summary

The combination of PECS II and parasternal Block provides analgesia after radical mastectomy

Detailed description

The cambionation of PECS II block and parasternal block

Interventions

PROCEDUREPECS II and parasternal block

10 ml of Levobupivacaine 0.375% injected between minor and major pectoralis muscles. 20 ml of Levobupivacaine 0.375% injected between minor and serratus muscles. 10 ml of Levobupivacaine 0.375% injected between major and intercostal muscles at II and IV intercostal space.

DRUGLevobupivacaine

Levobupivacaine

Sponsors

San Salvatore Hospital of L'Aquila
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* ASA status patients:1,2 and 3 * patients undergoing to radical mastectomy with axillary dissection and breast-implant reconstruction

Exclusion criteria

* patients with allergy to local anesthetics * ASA status patients: 4 * breast anatomy abnormalities * neurological diseases * septic conditions * coagulopathies * drug abuse history

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain: Numeric Rate Scale24 hours after surgeryPostoperative pain evaluated with Numeric Rate Scale, from 0 (no pain) to 10 (worst pain)

Secondary

MeasureTime frameDescription
Intraoperative opiatesFrom start to the end of surgeryNumber of patients needing of equianalgesic mg of intraoperative morphine
Postoperative opiates24 hours after surgeryNumber of patients needing of equianalgesic mg of postoperative morphine
Side effects24 hours after surgeryNumber of patients with postoperative nausea and vomiting

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026